Ergoteles’s AbCellera Biologics ABCL Stock Holding History

Ergoteles’s Portfolio ABCL Stock Details ABCL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$2.71M	Buy
2023 Q1	$264K	Buy
2021 Q4	–	Sell
2021 Q3	$6.64M	Buy
2021 Q2	$4.03M	Buy